Stonehearth Capital Management, LLC

Position in LLY — ELI LILLY & Co

CIK 1550191 DANVERS, MA

Position in LLY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$299,857

+$69,915 QoQ

Shares Held

250

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.50%

of 13F equity value

Holder Rank

#4,157

of 4,605 holders

Holding Since

Mar 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stonehearth Capital Management, LLC holds $1,506,955 across 5 Drug Manufacturers - General names. LLY ranks #2 (19.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,920	$487,622
2	LLY	ELI LILLY & Co This page	250	$299,857
3	PFE	Pfizer Inc	10,448	$251,587
4	MRK	Merck & Co., Inc.	1,896	$243,636
5	GILD	Gilead Sciences, Inc.	1,775	$224,253

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$299,857	250	0.0%	Shares	Sole	2026-07-07
2026-03-31	$229,942	250	0.0%	Shares	Sole	2026-04-17
2025-12-31	$268,670	250	0.0%	Shares	Sole	2026-01-13
2025-03-31	$206,477	250	0.0%	Shares	Sole	2025-04-01
2024-09-30	$221,485	250	-5.7%	Shares	Sole	2024-10-02
2024-06-30	$239,925	265	0.0%	Shares	Sole	2024-07-05
2024-03-31	$206,159	265	—	Shares	Sole	2024-04-02
No filing history on record for this holder in this stock.